Study to Evaluate Safety and Efficacy of EG-301 in Patients With Nonfocal Geographic Atrophy Secondary to Dry-AMD
Clinical trial NCT05170048 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05170048
- Sponsor
- Evergreen Therapeutics, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2028-06-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.